COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS Russian patent published in 2011 - IPC C07D207/16 C07D211/60 C07D265/30 C07D277/06 A61K31/40 A61K31/426 A61K31/445 A61K31/5375 A61P35/00 

Abstract RU 2424230 C2

FIELD: chemistry.

SUBSTANCE: invention relates to heterocyclic compounds of formula I

, where Y denotes -(C=O)-, X denotes -N(R10)-, A denotes -C(A1)(A2)-, B denotes O, S, -(C=O)- or is characterised by formula

, where D denotes N or CR10, and where the remaining substitutes are described in the claim. Compounds of formula I, as well as composition based on said compounds can inhibit the bcl-2 family proteins.

EFFECT: possibility of using said compounds and compositions in treating or modulating disorders associated with hyper-proliferation, such as cancer.

20 cl, 17 ex

Similar patents RU2424230C2

Title Year Author Number
COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS 2005
  • Kastro Al'Fredo S.
  • Dehn Vehj
  • Dip'Ju Kristofer M.
  • Foli Majkl A.
  • Fritts Kristian S.
  • Kheorkhes-Ehvankhelinos Asimina T.
  • Grogan Majkl Dzh.
  • Khafees Nafeesa
  • Kholson Ehduard B.
  • Khopkins Brajan T.
  • Koni Nil O.
  • Lju Tao
  • Mann Dejvid A.
  • Markaorelle Lajza A.
  • Snajder Daniel A.
  • Andervud Dennis Dzh.
  • Uajli Ehndr'Ju A.
  • Ju Lin'Chen'
  • Chzhan Lipin
RU2416606C2
PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES 2005
  • Kanne Bannen Linn
  • Chen Dzheff
  • Dehlrimpl Liza Ehster
  • Flehtt Brenton T.
  • Forsajt Timoti Patrik
  • Gu Sjao-Khoj
  • Mehk Morrison B.
  • Mann Larri U.
  • Mann Grejs
  • Martin Richard
  • Mokhan Radzhu
  • Merfi Brehtt
  • Najman Majkl Charl'Z
  • Stivens Uill'Jam K. Ml.
  • Van Te-Lin'
  • Van Jun
  • Vu Dzhejson Kh.
RU2470916C2
CYCLOPAMINE ANALOGUES AND METHODS OF THEIR APPLICATION 2005
  • Dzhanardanannair Somaradzhannair
  • Adams Dzhulian
  • Tremblehj Martin
  • Kastro Al'Fredo S.
  • Fouli Majkl A.
  • Nevalainen Marta
  • Porter Dzhejms R.
RU2403256C2
SPIROHETEROCYCLIC COMPOUNDS AND USE THEREOF AS THERAPEUTIC AGENTS 2006
  • Chafeev Mikhail
  • Chovdkhuri Sultan
  • Frejzer Robert
  • Fu Tszjan'Min'
  • Kambodzh Radzhender
  • Sviridov Sergej
  • Bagkherzadekh Mekhran Seid
  • Lju Shifehn
  • Sun' Tszjaniu
RU2428424C2
Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER 2010
  • Khotosi Jasumiti
  • Kholland Sasha
  • Pajjan Donal'D Dzh.
RU2555326C2
FGFR AND ITS MUTATION INHIBITOR, METHOD OF ITS PREPARATION AND USE 2021
  • Deng, Haibing
  • Ying, Haiyan
  • Yu, Hongping
  • Chen, Zhui
  • Xu, Yaochang
RU2811207C1
SUBSTITUTED NICOTINAMIDES AS KCNQ2-3 MODULATORS 2010
  • Sven Kjunert
  • Beatriks Merla
  • Gregor Barenberg
  • Vol'Fgang Shreder
RU2529904C2
ANTAGONISTS OF THROMBIN RECEPTOR 2005
  • Chakalamannil Samuehl'
  • Chellia Mariappan V.
  • Ksia Jan
  • Igen Kejt A.
RU2408594C2
COMPLEXES 2015
  • Colacot, Thomas
  • Chow, Ruishan
  • Jon Deangelis, Andrew
RU2682680C2
COMPLEXES 2015
  • Jon Deangelis, Andrew
  • Colacot, Thomas
RU2684934C2

RU 2 424 230 C2

Authors

Kastro Al'Fredo S.

Grogan Majkl Dzh.

Kholson Ehduard B.

Khopkins Brajan T.

Kouni Naj O.

Peljuzo Stefan

Snajder Daniel A.

Dates

2011-07-20Published

2006-12-15Filed